Frieda K. Chan, Ph.D.

Patent Agent

Background

Dr. Frieda Chan’s practice focuses on the drafting and prosecution of domestic and foreign patent applications, as well as assisting in the preparation of intellectual property due diligence, freedom to operate and patentability opinions. In 2015, Frieda received her Ph.D. specializing in reproductive, stem cell and molecular biology from Washington State University. As both an NIH molecular biosciences training fellow and an NSF biological and mathematical summer research fellow, her research focused on molecular mechanisms that regulate the germline stem cell population. In 2011, Frieda received a Postbaccalaureate in Microbiology and Mathematics from Washington State University.

Education

Washington State University
Molecular Biosciences
Ph.D. 2015

Washington State University
Microbiology and Mathematics
Postbaccalaureate 2011

Stony Brook University
Flute Performance
Doctorate of Musical Arts 2007

University of Michigan
Flute Performance
Master of Music 2003

San Francisco Conservatory of Music
Flute Performance
Bachelor of Music 2001

Experience

Frieda has extensive technical experience in cell and gene therapy, oncology and cancer therapeutics, biotechnology, immunology, reproductive biology, stem cell biology and molecular biology. Prior to joining Seed IP, Frieda worked at a multi-practice firm in Seattle, where she drafted provisional, utility, and PCT applications, responded to Office Actions, and conducted prior art searches and analyses for patentability and freedom to operate. Prior to this, she worked at the Fred Hutchinson Cancer Research Center (FHCRC) as a postdoctoral clinical research fellow in the laboratory of Hans-Peter Kiem, MD, PhD and a Business Development and Industry Relations (BDIR) Fellow. Frieda’s postdoctoral research focused on utilizing CRISPR/Cas technology to edit hematopoietic cells, improving vector and delivery systems for gene therapy and gene editing, enhancing engraftment of transplanted hematopoietic cells and developing clinical gene therapy protocols for hematopoietic diseases. As a BDIR fellow, she performed assessments describing novel technologies, market and competitive landscape analysis, prospective applications and potential company partnership.

Affiliations

Frieda is registered to practice before the U.S. Patent and Trademark Office. She is a member of the Washington State Patent Law Association (WSPLA), Life Science Washington, The American Society of Gene & Cell Therapy, American Society of Hematology, and Women in Biology.

Download Full Bio